Wyss Center for Bio and Neuroengineering Announces Venture with dEEGtal Insight: An Innovative Tool for Early Epilepsy Detection
10.12.2024 10:00:00 EET | Business Wire | Press release
The Wyss Center is proud to partner with dEEGtal Insight SA with a CHF 750,000 investment in its next stage of growth and development. dEEGtal Insight SA is a pioneering spin-off, of the Geneva University Hospitals (the EEG and Epilepsy Unit) and the University of Geneva, focused on transforming early detection and diagnosis of epilepsy. This forward-thinking initiative leverages advanced AI-powered software to deliver precise and timely insights to neurologists, enabling early intervention and better patient outcomes.
dEEGtal Insight SA’s technology addresses current challenges in diagnosing epilepsy by improving its detection accuracy and guiding clinicians toward informed decisions. Additionally, dEEGtal simplifies the EEG analysis process by offering automated medical reporting, automatic slowing detection, and a comprehensive overview of EEG signals.
“At the Wyss Center, we are committed to supporting projects that bring clear, tangible improvements to patient care,” said Erwin Böttinger, Director of The Wyss Center. “dEEGtal Insight represents a major step forward in epilepsy detection, and we are proud to support this innovation. This success underscores the strength of our collaboration with the Geneva University Hospitals and the University of Geneva, and it reflects the Wyss Center’s commitment to advancing healthcare technology that creates clinical and market impact.”
dEEGtal Insight marks a significant milestone in health technology and exemplifies the impact of partnerships between leading academic and medical institutions. Clinicians, researchers, and health-tech professionals are encouraged to learn more about this transformative tool and its potential to advance epilepsy diagnosis and treatment.
For more information, visit dEEGtal Insight’s website: www.deegtal.ai or the Wyss Center’s website at: www.wysscenter.ch.
About Wyss Center: The Wyss Center is an independent, not-for-profit organization focused on advancing neurotechnologies to improve the lives of people with neurological and mental health disorders. Based at Campus Biotech in Geneva, Switzerland, the Center develops transformative solutions in artificial intelligence, bioengineering, and neuroengineering to restore essential neural functions and deliver precision therapies. Established in 2014 with the support of Swiss entrepreneur and philanthropist Hansjörg Wyss, the Center collaborates with academic, clinical, and industry partners globally to drive innovation and maximize clinical impact.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241210321808/en/
Contacts
Eric Ménétré, dEEGtal Insight SA, info@deegtal.ai
Aldonza Gübeli, Wyss Center, aldonza.gubeli@wysscenter.ch, +41797015578
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NIQ (NYSE: NIQ) Unveils Six New AI-Powered Capabilities at C360, Executing on Its Vision for Agentic Commerce9.6.2026 22:00:00 EEST | Press release
NielsenIQ (NYSE: NIQ) today unveiled six new AI-powered capabilities at C360, the company's flagship client and industry event, marking a major milestone in the execution of NIQ’s AI strategy. Thenew capabilities help brands, retailers, and other organizations operationalize trusted market intelligence across enterprise workflows, AI environments, and the emerging world of agentic commerce. NIQ’s AI value creation strategy is built on two foundational principles: Delivering The Full View™: Combining the industry’s broadest and deepest datasets, advanced AI models, and rich content to help organizations unlock actionable insights and drive AI innovation at scale. Enabling AI-Powered Capabilities: Delivering trusted intelligence and proprietary IP through NIQ’s advanced AI applications, assistants, and agents embedded within client workflows and enterprise environments. Together, these principles reinforce NIQ’s position as the trusted intelligence infrastructure powering the future of c
H55 Delivers Certification-Grade Propulsion Battery Modules to Pratt & Whitney Canada, Supporting Demonstration of Hybrid-Electric Aircraft Technology9.6.2026 18:31:00 EEST | Press release
H55 today announced the delivery of certification-grade propulsion battery modules to Pratt & Whitney Canada in support of the RTX Hybrid-Electric Flight Demonstrator — a milestone that further validates H55’s transition from technology development to industrial-scale execution and represents an important step in the commercialization of the company’s certification-grade energy storage technologies for hybrid-electric aerospace applications. Pratt & Whitney is an RTX business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609825006/en/ H55 Adagio Battery Modules in Pratt & Whitney Canada Hangar ©RTX The delivery represents more than hardware integration. It demonstrates H55’s ability to manufacture production-conforming propulsion systems within a regulator-approved environment and deploy them into active aircraft integration and flight-test programs — a capability achieved today by only a small number of companies globa
New Polymorph of Indomethacin Discovered9.6.2026 18:00:00 EEST | Press release
Rigaku Corporation, a global solution partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), announced that the results of a joint research project conducted with Shionogi & Co., Ltd., JEOL Ltd., and Meiji Pharmaceutical University have been published in Crystal Growth & Design, a world-renowned international journal in the field of crystallography. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609347405/en/ Cover of the June 2026 issue of Crystal Growth & Design, featuring this research. This research uncovered a previously unknown polymorph (κ-form) of indomethacin, a widely used pain relief and anti-inflammatory drug. The research team also conducted structural analysis and characterization of the newly identified crystal form. Although indomethacin has been the subject of pharmaceutical research for years, the discovery of a
SLB Collaborates with Qualcomm on Edge AI Solutions for Energy Operations9.6.2026 17:28:00 EEST | Press release
Global energy technology company SLB (NYSE: SLB) today announced a memorandum of understanding with Qualcomm Technologies, Inc. to enable edge AI solutions for the energy industry, supporting real-time operational decision-making across wells, facilities and production systems. The collaboration combines Qualcomm Technologies’ low-power edge computing and AI processing capabilities, with SLB’s Agora™ edge AI and IoT solutions developed for remote and operationally complex environments. “Together, SLB and Qualcomm Technologies aim to help operators apply AI more effectively across energy infrastructure,” said Rakesh Jaggi, president, Digital, SLB. “Many energy operations rely on real-time decision-making in remote environments where connectivity and responsiveness directly affect performance. AI systems designed around the realities of energy operations can help support more consistent and autonomous workflows across those environments.” Energy operators are increasingly adopting automa
RevBits and Stony Brook University’s Ethos Lab Establish a Collaborative Partnership to Further the Field of Cyber Security Education and Application9.6.2026 17:15:00 EEST | Press release
Stony Brook University’s (SBU) Ethos Lab, in the College of Engineering and Applied Sciences Department of Computer Science, recently announced a collaborative partnership with RevBits, LLC. Through the partnership, SBU’s Ethos Lab will utilize the RevBits solutions suite to build computer science labs and a cybersecurity-focused curriculum, reinforcing lessons from the classroom. The platform simulates environments containing five major threat landscapes, including Endpoint Security, Privileged Access Management, Email Security, Zero Trust Network and Deception Technology. SBU’s Department of Computer Science was recently designated as a National Center of Academic Excellence in Cybersecurity Research and will utilize the partnership to advance student education and equip them with the knowledge to face modern threats in a realistic, contained environment. David Schiffer, CEO, RevBits, said, "We are incredibly proud to participate in the educational process in general and specifically
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom